Desmond Kidd
Introduction
Dr Desmond Kidd is a consultant neurologist who worked at the Royal Free London NHS Foundation Trust from 2009 to 2022, with a particular interest in neurosarcoidosis, and was suspended from the medical register for twelve months by a Medical Practitioners Tribunal in March 2026, after findings that he had been dishonest in research articles, about a patient’s diagnosis and treatment funding, and about contact with former patients after he left the trust. The tribunal sat between 23 February and 13 March 2026, imposed an immediate order, and directed a review .
Background Information
The case gathers three separate dishonesty threads into one determination. The first is academic: research articles published between June 2019 and July 2020 carried an affiliation claim that was not true. The second is clinical and financial: statements made about a patient identified as Patient B — her diagnosis, the funding of her treatment and the evidence said to support it. The third is post-employment: Kidd’s continuing contact with former patients after he left the trust in August 2022, and what he said about it when asked .
The Controversy or Incident That Led to Their Cancellation
Adjudicated (regulatory), not a criminal case. The findings below were made by a Medical Practitioners Tribunal applying the civil standard of proof in a fitness-to-practise process. They are not a criminal conviction, and nothing in the fetched record establishes any prosecution.
The tribunal found proved that between June 2019 and July 2020 Kidd produced research articles dishonestly stating an affiliation with the Institute of Immunity and Transplantation at University College London when he had no such affiliation. In relation to Patient B, it found he dishonestly stated that she had Chronic Inflammatory Demyelinating Polyneuropathy when he knew she did not, dishonestly claimed that funding for her treatment had been approved by the IVIG Panel, and dishonestly stated that there was electrophysiological evidence for a small fibre neuropathy. After his departure from the trust in August 2022, it found he continued to correspond with former patients giving clinical advice, dishonestly denied doing so, and attempted to access their medical records .
The tribunal placed the dishonesty at the higher end of the spectrum of seriousness: it was persistent and continued over a prolonged period, involved elements of premeditation particularly in respect of Patient B, occurred within his professional role, and showed a reckless disregard for professional standards. It found the conduct undermined the systems designed to protect the public and undermined collaborative working, and that Kidd had shown no insight or remediation — in correspondence he described the allegations as “a manifestation of management irritation and misrepresentation”. The clinical concerns regarding Patient B were separately found to amount to serious misconduct, and his fitness to practise was found impaired on all three parts of the overarching objective .
On sanction, the tribunal suspended his registration for twelve months with an immediate order and directed a review hearing .
Public Reaction and Consequences
The concrete consequence is the twelve-month suspension with the immediate order attached, which removed Kidd from practice from March 2026 pending review. The case is recorded in MedicWatch’s listing of doctors suspended in 2026; no public statement from Kidd, the trust or any journal appears in the fetched record beyond the tribunal’s determination. Whether the journals carrying the affiliation claims have issued corrections is not shown by the fetched record, and nothing here should be read as establishing that they have .
A consultant found to have invented an academic affiliation and a diagnosis, and to have misstated funding approvals, sits at the intersection the regulator guards most closely: research integrity and patient care in the same dishonest pattern .
Current Status
Kidd is a suspended doctor under a twelve-month order imposed on 13 March 2026, in force immediately, with a review directed before it ends. The tribunal’s finding of no insight or remediation — anchored in his own characterisation of the allegations — is the standing obstacle: a panel at review must find genuine engagement before any return can be contemplated, and the twelve-month term positions erasure as the next step if it is not .
Impact on Their Career/Life
Higher-end dishonesty findings spanning publications, clinical claims and post-employment conduct end a consultant’s credibility in research, clinical practice and private advice all at once. The immediate order meant the loss of registration began the day of the decision, and the “management irritation” framing the tribunal recorded will confront him at every future hearing .